In contrast to CD19 and BCMA, which are highly specific B-cell antigens, solid tumor-associated antigens are overexpressed in solid tumors and on healthy tissue leading to reports of fatal pulmonary toxicity and encephalitis in early stage trials [136,137]. This evidence concerns the gene TNFRSF17 and encephalitis.